Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese journal of integrative medicine ; (12): 624-628, 2020.
Artigo em Inglês | WPRIM | ID: wpr-827482

RESUMO

OBJECTIVE@#To help selecting appropriate meridians and acupoints in clinical practice and experimental study for Parkinson's disease (PD), the rules of meridians and acupoints selection of acupuncture and moxibustion were analyzed in domestic and foreign clinical treatment for PD based on data mining techniques.@*METHODS@#Literature about PD treated by acupuncture and moxibustion in China and abroad was searched and selected from China National Knowledge Infrastructure and MEDLINE. Then the data from all eligible articles were extracted to establish the database of acupuncture-moxibustion for PD. The association rules of data mining techniques were used to analyze the rules of meridians and acupoints selection.@*RESULTS@#Totally, 168 eligible articles were included and 184 acupoints were applied. The total frequency of acupoints application was 1,090 times. Those acupoints were mainly distributed in head and neck and extremities. Among all, Taichong (LR 3), Baihui (DU 20), Fengchi (GB 20), Hegu (LI 4) and Chorea-tremor Controlled Zone were the top five acupoints that had been used. Superior-inferior acupoints matching was utilized the most. As to involved meridians, Du Meridian, Dan (Gallbladder) Meridian, Dachang (Large Intestine) Meridian, and Gan (Liver) Meridian were the most popular meridians.@*CONCLUSIONS@#The application of meridians and acupoints for PD treatment lay emphasis on the acupoints on the head, attach importance to extinguishing Gan wind, tonifying qi and blood, and nourishing sinews, and make good use of superior-inferior acupoints matching.

2.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 143-146, 2004.
Artigo em Chinês | WPRIM | ID: wpr-320227

RESUMO

<p><b>OBJECTIVE</b>To observe the effect of Yirong Oral Liquid (YROL) on reperfusion injury in rats with cerebral infarction undergoing thrombolysis.</p><p><b>METHODS</b>Clinical reperfusion under thrombolysis was simulated by applying thrombolysis on reversible local cerebral ischemic rat model. In the rat model, effect of YROL on parameters concerning anti-oxidation capability, cerebral edema and ultrastructure of brain were observed.</p><p><b>RESULTS</b>YROL could alleviate the cerebral edema after reperfusion, markedly increase the activity of superoxide dismutase in blood plasma, decrease the content of malonyldialdehyde, inhibit the post-reperfusion lipid peroxidation, and significantly reduce the ischemia/reperfusion injury of nerve cells in brain of rat.</p><p><b>CONCLUSION</b>YROL has definite protecting effect on brain.</p>


Assuntos
Animais , Masculino , Ratos , Infarto Cerebral , Tratamento Farmacológico , Patologia , Quimioterapia Combinada , Medicamentos de Ervas Chinesas , Usos Terapêuticos , Malondialdeído , Sangue , Fármacos Neuroprotetores , Usos Terapêuticos , Fitoterapia , Ratos Sprague-Dawley , Traumatismo por Reperfusão , Superóxido Dismutase , Sangue , Terapia Trombolítica , Ativador de Plasminogênio Tipo Uroquinase , Usos Terapêuticos
3.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 50-53, 2002.
Artigo em Chinês | WPRIM | ID: wpr-304250

RESUMO

<p><b>OBJECTIVE</b>To observe the effect of Bushen Yizhi Recipe (BSYZR) on neurotransmitter release in A beta segment neurotoxin induced NG108-15 cellular model of Alzheimer disease (AD).</p><p><b>METHODS</b>The levels of choline acetyltransferase (ChAT) activity, synapsin and functional synapse formation rate in the cellular model treated with BSYZR containing serum were determined by Western blot analysis, immunoradiometric assay and electrophysiologic technique.</p><p><b>RESULTS</b>BSYZR containing serum treatment could cause increase of ChAT activity and synapsin level in model cells, as compared with those in normal control model cells treated with non-drug containing serum, it also could regulate the release capacity of transmitter and raise the functional synapse formation.</p><p><b>CONCLUSION</b>BSYZR could reduce the reaction of cell to A beta neurotoxin, indicating that it could be antagonistic to the pathological development of AD by means of raising the neurotransmitter release capacity.</p>


Assuntos
Animais , Ratos , Doença de Alzheimer , Metabolismo , Patologia , Peptídeos beta-Amiloides , Metabolismo , Linhagem Celular , Colina O-Acetiltransferase , Metabolismo , Medicamentos de Ervas Chinesas , Farmacologia , Neurotoxinas , Farmacologia , Neurotransmissores , Metabolismo , Distribuição Aleatória , Ratos Wistar , Sinapsinas , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA